image
ACADIA Pharmaceuticals Inc. ACAD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 21.34
-1.98 %
$ 3.57 B
Market Cap
15.58
P/E
Price Target Average
19.83%
Revenue Forecast Estimate
14.26%
EBIT Estimate
--32.21%
Net Income Estimate
16.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets ACADIA Pharmaceuticals Inc.
image
Wall Street analysts predict an average 1-year price target for ACAD of $25.6 , with forecasts ranging from a low of $20 to a high of $32 .
ACAD Lowest Price Target Wall Street Target
20 USD -6.28%
ACAD Average Price Target Wall Street Target
25.6 USD 19.83%
ACAD Highest Price Target Wall Street Target
32 USD 49.95%
Price
Max Price Target
Min Price Target
Average Price Target
3232303028282626242422222020181816161414Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart ACAD

image
$1.8b$1.8b$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ACAD

image
$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ACAD

image
$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029